利德曼：11月13日召开董事会会议

Group 1 - Lidman (SZ 300289) announced on November 13 that its sixth board meeting was held to review a proposal for significant asset restructuring [1] - For the first half of 2025, Lidman's revenue composition was as follows: 86.79% from the biopharmaceutical sector, 12.96% from property leasing, and 0.25% from other businesses [1] - As of the report date, Lidman's market capitalization was 4.9 billion yuan [1] Group 2 - The news highlighted a trend where banks are selling previously owned properties at significant discounts, with some properties being sold at half price [1] - There is a high demand for these bank-owned properties, with reports of buyers willing to pay an additional 1 million yuan to secure a purchase [1]